Seeing Is Believing
Currently out of the existing stock ratings of Brandon Folkes, 104 are a BUY (84.55%), 1 are a SELL (0.81%), 18 are a HOLD (14.63%).
Analyst Brandon Folkes, currently employed carries an average stock price target met ratio of 28.89% that have a potential upside of 14.22% achieved within 136 days. Previously, Brandon Folkes worked at CANTOR FITZGERALD.
Brandon Folkesās has documented 231 price targets and ratings displayed on 25 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on OMER, Omeros at 10-Nov-2023.
Analyst best performing recommendations are on VRAY (VIEWRAY).
The best stock recommendation documented was for COLL (COLLEGIUM PHARMACEUTICAL) at 1/6/2020. The price target of $24 was fulfilled within 9 days with a profit of $3.69 (18.17%) receiving and performance score of 20.19.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
6
$0.41 (7.33%)
8
2 years 5 months 2 days ago
1/4 (25%)
$2.17 (44.83%)
281
Hold
5.6
$0.01 (0.18%)
2 years 5 months 12 days ago
1/1 (100%)
$0.04 (0.72%)
34
Hold
4.5
$-1.09 (-19.50%)
2 years 6 months 5 days ago
4/4 (100%)
$1.14 (33.93%)
167
Buy
6.25
$0.66 (11.81%)
5
3 years 2 months 21 days ago
1/2 (50%)
$3.07 (96.54%)
287
Buy
8
$2.41 (43.11%)
4 years 8 months 14 days ago
1/2 (50%)
$2.26 (36.00%)
1683
What Year was the first public recommendation made by Brandon Folkes?